Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine
Michail Vikelis,1 Dimos D Mitsikostas,2 Alan M Rapoport31Glyfada Headache Center, Glyfada, Greece; 2Neurology Department, Athens Naval Hospital, Athens, Greece; 3The David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Migraine is a chronic, painful, and often disabling primary hea...
Guardado en:
Autores principales: | Vikelis M, Mitsikostas DD, Rapoport AM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/613f0fffd51b466fadfee1875b2c3575 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients
por: Brand-Schieber E, et al.
Publicado: (2016) -
Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
por: Teaima M, et al.
Publicado: (2021) -
The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats
por: Bulboacă AE, et al.
Publicado: (2018) -
Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine
por: Tepper SJ, et al.
Publicado: (2018) -
Transdermal Patches for Delivery of Beta-Blockers
por: Rohaľová S., et al.
Publicado: (2021)